Mezzion Pharma Co.,Ltd. (140410.KQ)
KRW 32600.0
(-5.37%)
KRW 32600.0
(-5.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -11.02 Billion | -12.07 Billion | -15.07 Billion | -7.37 Billion | -20.88 Billion |
| Net Income | -12.72 Billion | -36.29 Billion | -13.5 Billion | -13.82 Billion | -23.25 Billion |
| Depreciation & Amortization | 1.54 Billion | 1.65 Billion | 1.58 Billion | 1.43 Billion | 1.33 Billion |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 421.61 Million | 1.29 Billion | 2.53 Billion | 1.13 Billion | - |
| Change in working capital | 785.58 Million | 5.93 Billion | -1.13 Billion | -3.2 Billion | -2.1 Billion |
| Other non-cash items | -1.06 Billion | -340.17 Million | 17.03 Million | 2.9 Billion | 3.14 Billion |
| Investing Cash Flow | -25.55 Billion | 17.4 Billion | -16.33 Billion | 3.56 Billion | 304.46 Million |
| Investments in PPE | -11.85 Billion | -1.76 Billion | -6.18 Billion | -7.95 Billion | -1.09 Billion |
| Acquisitions | 1.19 Billion | - | - | - | - |
| Investment purchases | -20 Billion | -1.15 Billion | -32.87 Billion | -15.45 Billion | - |
| Sales/Maturities of investments | 5.03 Billion | 20.3 Billion | 23.01 Billion | 26.96 Billion | - |
| Other Investing Activities | 190.00 | 5.1 Million | -284.39 Million | 4.33 Billion | -310.00 |
| Financing Cash Flow | 47.21 Billion | -615.78 Million | 19.11 Billion | 24 Billion | 6.76 Billion |
| Debt repayment | -550.13 Million | -228.82 Million | -42.44 Million | -578.75 Million | -1.05 Billion |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 48.65 Billion | 312 Million | 225.77 Million | 24.51 Billion | - |
| Other Financing Activities | -10.00 | 540.82 Million | 20 Billion | 25.09 Billion | -10.00 |
| Accounts receivables | 245.93 Million | -150.69 Million | 308.72 Million | 234.23 Million | -1.13 Billion |
| Accounts payables | - | - | - | - | - |
| Inventory | 2.64 Billion | -313.16 Million | -4.78 Billion | -3.95 Billion | -715.77 Million |
| Other working capital | 1.04 Billion | 4.92 Billion | 1.55 Billion | 596.37 Million | -261 Million |
| Cash at beginning of period | 29.39 Billion | 24.2 Billion | 35.85 Billion | 15.64 Billion | 29.55 Billion |
| Cash at end of period | 40.24 Billion | 29.39 Billion | 24.2 Billion | 35.85 Billion | 15.64 Billion |
| Capital Expenditure | -11.85 Billion | -1.76 Billion | -6.18 Billion | -7.95 Billion | -1.09 Billion |
| Effect of forex changes on cash | 211.85 Million | 470.01 Million | 648.85 Million | 16.75 Million | -93.2 Million |
| Net cash flow / Change in cash | 10.84 Billion | 5.18 Billion | -11.64 Billion | 20.2 Billion | -13.9 Billion |
| Free Cash Flow | -22.88 Billion | -13.83 Billion | -21.25 Billion | -15.33 Billion | -21.97 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.61 Billion | 72.59 Million | -6.34 Billion | -12.72 Billion | -977.88 Million | -2.9 Billion |
| Depreciation & Amortization | 233.06 Million | 254.3 Million | 406.89 Million | 1.54 Billion | 385.04 Million | 384.32 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 484.79 Million | 463.48 Million | 49.6 Million | 421.61 Million | - | - |
| Change in working capital | -9.45 Billion | 1.66 Billion | 1.02 Billion | 785.58 Million | 6.71 Billion | -4.99 Billion |
| Other non-cash items | -441.56 Million | -371.53 Million | -395.49 Million | -1.06 Billion | -458.43 Million | -63.03 Million |
| Investing Cash Flow | 905.53 Million | -3.51 Billion | 752.92 Million | -25.55 Billion | -5.55 Billion | -20.69 Billion |
| Investments in PPE | -137.31 Million | -3.51 Billion | -5.59 Billion | -11.85 Billion | -5.46 Billion | -712.16 Million |
| Acquisitions | - | - | 1.19 Billion | 1.19 Billion | - | - |
| Investment purchases | - | - | 100.77 Million | -20 Billion | -100.77 Million | -19.99 Billion |
| Sales/Maturities of investments | - | - | 4.99 Billion | 5.03 Billion | 10 Million | 1.5 Million |
| Other Investing Activities | 1.04 Billion | -3.12 Billion | 180.00 | 190.00 | -5.55 Billion | -20.43 Billion |
| Financing Cash Flow | -172.17 Million | 85.97 Million | -137.14 Million | 47.21 Billion | -500.83 Million | 48.5 Billion |
| Debt repayment | -716.58 Million | -217 Million | -232.62 Million | -550.13 Million | -127.86 Million | -190.87 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -3.84 Billion | - | - | - |
| Common Stock Issuance | - | - | -3.84 Billion | 48.65 Billion | 4.01 Billion | - |
| Other Financing Activities | 544.4 Million | 10.00 | 4 Billion | -10.00 | -500.83 Million | 48.5 Billion |
| Accounts receivables | -70.73 Million | 1.16 Billion | 1.38 Billion | 245.93 Million | -701.2 Million | -71.32 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -870.3 Million | -11.16 Million | 1.63 Billion | 2.64 Billion | -180.98 Million | 373.44 Million |
| Other working capital | -8.51 Billion | 2.81 Billion | -739.56 Million | 1.04 Billion | 5.63 Billion | -3.08 Billion |
| Cash at beginning of period | 35.63 Billion | 40.24 Billion | 41.5 Billion | 29.39 Billion | 42.98 Billion | 22.86 Billion |
| Cash at end of period | 23.12 Billion | 35.63 Billion | 40.24 Billion | 40.24 Billion | 41.5 Billion | 42.98 Billion |
| Capital Expenditure | -137.31 Million | -3.51 Billion | -5.59 Billion | -11.85 Billion | -5.46 Billion | -712.16 Million |
| Effect of forex changes on cash | 17.16 Million | 290.57 Million | 198.71 Million | 211.85 Million | -167.62 Million | 149.16 Million |
| Net cash flow / Change in cash | -12.51 Billion | -4.61 Billion | -1.25 Billion | 10.84 Billion | -1.48 Billion | 20.11 Billion |
| Free Cash Flow | -13.4 Billion | -4.98 Billion | -7.66 Billion | -22.88 Billion | -726.96 Million | -8.55 Billion |
6835
AQN
CABA
SHOP
7868
ELLO